Effects of PF1022A on adultAngiostrongylus cantonensis in the pulmonary arteries and larvae migrating into the central nervous system of rats
Author(s) -
Shigeo Kachi,
Akira Ishih,
M. Terada
Publication year - 1995
Publication title -
zeitschrift für parasitenkunde parasitology research
Language(s) - English
Resource type - Journals
ISSN - 0044-3255
DOI - 10.1007/bf00931838
Subject(s) - angiostrongylus cantonensis , anthelmintic , feces , larva , biology , central nervous system , physiology , intraperitoneal injection , helminths , medicine , endocrinology , immunology , zoology , ecology
We examined the effects of PF1022A, newly developing in Japan, on adult Angiostrongylus cantonensis in the pulmonary arteries of rats. Following five and ten successive oral doses at 10 mg/kg per day, the first-stage larvae in rat faeces disappeared completely at 2 weeks after treatment. The treatment completely killed the female worms, but not the male worms. However, numbers of male worms were also decreased after the administration of either five successive oral doses at 10 mg/kg per day for four courses or five successive intraperitoneal doses at 0.5 mg/kg per day. Next, we examined the effects of PF1022A on larval A. cantonensis migrating into the central nervous system (CNS) of rats. Following five successive oral doses at 5 or 10 mg/kg per day and five successive intraperitoneal doses at 0.5 mg/kg per day, lesser killing effects were observed on male as well as female worms. On the basis of these results it is apparent that PF1022A will become a promising anthelmintic available as treatment for tissue-dwelling as well as intestinal nematodes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom